ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
FRA:EUZ - Deutsche Boerse Ag - DE0005659700 - Common Stock - Currency: EUR
We assign a fundamental rating of 7 out of 10 to EUZ. EUZ was compared to 60 industry peers in the Health Care Equipment & Supplies industry. EUZ gets an excellent profitability rating and is at the same time showing great financial health properties. EUZ is growing strongly while it is still valued neutral. This is a good combination! This makes EUZ very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year EUZ was profitable.
In the past year EUZ had a positive cash flow from operations.
EUZ had positive earnings in each of the past 5 years.
Each year in the past 5 years EUZ had a positive operating cash flow.
1.2 Ratios
EUZ has a better Return On Assets (6.11%) than 81.67% of its industry peers.
EUZ has a Return On Equity of 11.83%. This is amongst the best in the industry. EUZ outperforms 81.67% of its industry peers.
With an excellent Return On Invested Capital value of 11.18%, EUZ belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EUZ is in line with the industry average of 7.96%.
The 3 year average ROIC (8.25%) for EUZ is below the current ROIC(11.18%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.11% | ||
| ROE | 11.83% | ||
| ROIC | 11.18% |
ROA(3y)7.7%
ROA(5y)7.7%
ROE(3y)14.69%
ROE(5y)14.93%
ROIC(3y)8.25%
ROIC(5y)8.45%
1.3 Margins
EUZ has a Profit Margin of 10.58%. This is in the better half of the industry: EUZ outperforms 73.33% of its industry peers.
In the last couple of years the Profit Margin of EUZ has grown nicely.
EUZ has a Operating Margin of 21.70%. This is amongst the best in the industry. EUZ outperforms 91.67% of its industry peers.
EUZ's Operating Margin has improved in the last couple of years.
EUZ has a Gross Margin (48.01%) which is in line with its industry peers.
EUZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.7% | ||
| PM (TTM) | 10.58% | ||
| GM | 48.01% |
OM growth 3Y3.25%
OM growth 5Y8.66%
PM growth 3Y-4.02%
PM growth 5Y2.25%
GM growth 3Y-1.27%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
EUZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, EUZ has about the same amount of shares outstanding.
The number of shares outstanding for EUZ has been increased compared to 5 years ago.
Compared to 1 year ago, EUZ has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.01 indicates that EUZ is not in any danger for bankruptcy at the moment.
EUZ has a Altman-Z score of 5.01. This is amongst the best in the industry. EUZ outperforms 86.67% of its industry peers.
The Debt to FCF ratio of EUZ is 1.53, which is an excellent value as it means it would take EUZ, only 1.53 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.53, EUZ belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
EUZ has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
EUZ has a Debt to Equity ratio of 0.17. This is in the better half of the industry: EUZ outperforms 78.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 1.53 | ||
| Altman-Z | 5.01 |
ROIC/WACC1.62
WACC6.9%
2.3 Liquidity
EUZ has a Current Ratio of 2.77. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
EUZ's Current ratio of 2.77 is fine compared to the rest of the industry. EUZ outperforms 76.67% of its industry peers.
EUZ has a Quick Ratio of 2.32. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.32, EUZ is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.77 | ||
| Quick Ratio | 2.32 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.52% over the past year.
The Earnings Per Share has been growing by 10.06% on average over the past years. This is quite good.
EUZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.70%.
Measured over the past years, EUZ shows a small growth in Revenue. The Revenue has been growing by 7.84% on average per year.
EPS 1Y (TTM)9.52%
EPS 3Y6.9%
EPS 5Y10.06%
EPS Q2Q%-44.42%
Revenue 1Y (TTM)14.7%
Revenue growth 3Y11.79%
Revenue growth 5Y7.84%
Sales Q2Q%6.38%
3.2 Future
EUZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.10% yearly.
EUZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.10% yearly.
EPS Next Y55.27%
EPS Next 2Y39.32%
EPS Next 3Y29.1%
EPS Next 5YN/A
Revenue Next Year21.88%
Revenue Next 2Y15.43%
Revenue Next 3Y13.1%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 41.27, which means the current valuation is very expensive for EUZ.
The rest of the industry has a similar Price/Earnings ratio as EUZ.
EUZ's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.90.
The Price/Forward Earnings ratio is 24.52, which indicates a rather expensive current valuation of EUZ.
EUZ's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.58. EUZ is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.27 | ||
| Fwd PE | 24.52 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EUZ indicates a somewhat cheap valuation: EUZ is cheaper than 78.33% of the companies listed in the same industry.
EUZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EUZ is cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.55 | ||
| EV/EBITDA | 15.56 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EUZ may justify a higher PE ratio.
EUZ's earnings are expected to grow with 29.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)4.1
EPS Next 2Y39.32%
EPS Next 3Y29.1%
5. Dividend
5.1 Amount
With a yearly dividend of 0.09%, EUZ is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.28, EUZ has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, EUZ's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.09% |
5.2 History
On average, the dividend of EUZ grows each year by 20.17%, which is quite nice.
Dividend Growth(5Y)20.17%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EUZ pays out 3.55% of its income as dividend. This is a sustainable payout ratio.
The dividend of EUZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.55%
EPS Next 2Y39.32%
EPS Next 3Y29.1%
FRA:EUZ (3/14/2025, 7:00:00 PM)
56.95
+1.55 (+2.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners23.35%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.21B
Analysts83.33
Price Target64.41 (13.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.09% |
Yearly Dividend0.5
Dividend Growth(5Y)20.17%
DP3.55%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.13%
PT rev (3m)8.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.14%
EPS NY rev (3m)0.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.86%
Revenue NY rev (3m)5.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.27 | ||
| Fwd PE | 24.52 | ||
| P/S | 4.34 | ||
| P/FCF | 35.55 | ||
| P/OCF | 22.83 | ||
| P/B | 4.85 | ||
| P/tB | 6.15 | ||
| EV/EBITDA | 15.56 |
EPS(TTM)1.38
EY2.42%
EPS(NY)2.32
Fwd EY4.08%
FCF(TTM)1.6
FCFY2.81%
OCF(TTM)2.49
OCFY4.38%
SpS13.12
BVpS11.74
TBVpS9.25
PEG (NY)0.75
PEG (5Y)4.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.11% | ||
| ROE | 11.83% | ||
| ROCE | 15.82% | ||
| ROIC | 11.18% | ||
| ROICexc | 15.03% | ||
| ROICexgc | 18.45% | ||
| OM | 21.7% | ||
| PM (TTM) | 10.58% | ||
| GM | 48.01% | ||
| FCFM | 12.21% |
ROA(3y)7.7%
ROA(5y)7.7%
ROE(3y)14.69%
ROE(5y)14.93%
ROIC(3y)8.25%
ROIC(5y)8.45%
ROICexc(3y)11.04%
ROICexc(5y)12.05%
ROICexgc(3y)15.63%
ROICexgc(5y)17.16%
ROCE(3y)11.67%
ROCE(5y)11.96%
ROICexcg growth 3Y-10.1%
ROICexcg growth 5Y-4.01%
ROICexc growth 3Y-6.74%
ROICexc growth 5Y1.56%
OM growth 3Y3.25%
OM growth 5Y8.66%
PM growth 3Y-4.02%
PM growth 5Y2.25%
GM growth 3Y-1.27%
GM growth 5Y1.38%
F-Score8
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 1.53 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 132.5% | ||
| Cap/Sales | 6.81% | ||
| Interest Coverage | 46.86 | ||
| Cash Conversion | 70.87% | ||
| Profit Quality | 115.42% | ||
| Current Ratio | 2.77 | ||
| Quick Ratio | 2.32 | ||
| Altman-Z | 5.01 |
F-Score8
WACC6.9%
ROIC/WACC1.62
Cap/Depr(3y)260.24%
Cap/Depr(5y)182.43%
Cap/Sales(3y)13.56%
Cap/Sales(5y)9.75%
Profit Quality(3y)22.91%
Profit Quality(5y)70.07%
High Growth Momentum
Growth
EPS 1Y (TTM)9.52%
EPS 3Y6.9%
EPS 5Y10.06%
EPS Q2Q%-44.42%
EPS Next Y55.27%
EPS Next 2Y39.32%
EPS Next 3Y29.1%
EPS Next 5YN/A
Revenue 1Y (TTM)14.7%
Revenue growth 3Y11.79%
Revenue growth 5Y7.84%
Sales Q2Q%6.38%
Revenue Next Year21.88%
Revenue Next 2Y15.43%
Revenue Next 3Y13.1%
Revenue Next 5YN/A
EBIT growth 1Y46.62%
EBIT growth 3Y15.43%
EBIT growth 5Y17.18%
EBIT Next Year64.7%
EBIT Next 3Y26.38%
EBIT Next 5YN/A
FCF growth 1Y481.5%
FCF growth 3Y-25.74%
FCF growth 5Y-5.42%
OCF growth 1Y83.05%
OCF growth 3Y2.56%
OCF growth 5Y12.19%